News
Autolus Therapeutics (AUTL) confirmed that the U.K. Medicines and Healthcare products Regulatory Agency has granted ...
Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at ...
As with all products, the MHRA will keep its safety under close review. The Medicines and Healthcare products Regulatory ...
A Tapestry high school senior never imagined his senior year would be interrupted by a cancer diagnosis. Dakarai Jackson Jr.
Obe-cel is under regulatory review in both the EU and the U.K., and the Company expects to receive notification of approval status from the Medicines and Healthcare products Regulatory Agency (MHRA) ...
Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk ...
Allogene Therapeutics, Inc.’s ALLO share price has surged by 5.28%, which has investors questioning if this is right time to ...
Now, Kaufman, a 20-year-old sophomore baseball player and business finance major at Roanoke College, is facing his toughest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results